Standout Papers

From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heteroc... 2018 2026 2020 2023 275
  1. From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles (2018)
    Michael D. Delost, David T. Smith et al. Journal of Medicinal Chemistry

Immediate Impact

2 by Nobel laureates 7 from Science/Nature 68 standout
Sub-graph 1 of 23

Citing Papers

Sulfenylnitrene-mediated nitrogen-atom insertion for late-stage skeletal editing of N -heterocycles
2025 StandoutScience
Unlocking Chiral Sulfinimidoyl Electrophiles: Asymmetric Synthesis of Sulfinamides Catalyzed by Anionic Stereogenic-at-Cobalt(III) Complexes
2025 Standout
2 intermediate papers

Works of Michael D. Delost being referenced

From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles
2018 Standout
A Survey of the Structures of US FDA Approved Combination Drugs
2018

Author Peers

Author Last Decade Papers Cites
Michael D. Delost 464 58 105 61 9 550
T. V. Sravanthi 529 28 96 78 6 604
Muthukumar G. Sankar 471 25 150 66 16 542
Hong X. Ding 396 106 207 82 12 597
Owen A. Davis 563 69 136 89 8 647
Thomas J. Osberger 488 30 186 103 7 586
Marc Blouin 461 62 155 50 15 645
Christopher K. Murray 559 30 90 69 12 641
Damien Valette 508 18 106 76 13 645
Priyadeep Bhutani 420 68 175 64 18 647
Kerstin Hiesinger 404 25 96 53 12 502

All Works

Loading papers...

Rankless by CCL
2026